Tom Bird serves as a Managing Director at Stifel Financial Corp, where he leverages his extensive expertise in healthcare investment banking to drive strategic growth and value creation for clients in the pharmaceutical and biopharmaceutical sectors. With a robust background in corporate development and mergers...
Tom Bird serves as a Managing Director at Stifel Financial Corp, where he leverages his extensive expertise in healthcare investment banking to drive strategic growth and value creation for clients in the pharmaceutical and biopharmaceutical sectors. With a robust background in corporate development and mergers and acquisitions, Tom has successfully led numerous high-profile transactions across a diverse range of areas, including generics, regenerative medicine, life science tools, diagnostics, medical devices, and pharma services. His strategic insights and adept negotiation skills have been instrumental in facilitating partnerships and licensing agreements that enhance the competitive positioning of his clients.
Since the acquisition of Torreya by Stifel in March 2023, Tom has played a pivotal role in integrating Torreya’s capabilities into Stifel’s broader investment banking platform. His focus on licensing pharma products and supporting research-driven companies underscores his commitment to fostering innovation within the healthcare landscape. Tom's proficiency in due diligence and general management further enables him to navigate complex transactions, ensuring that all aspects of a deal are meticulously evaluated and aligned with client objectives.
With a Bachelor of Arts in Economics and Accounting, Tom combines analytical rigor with a strong entrepreneurial spirit, making him a trusted advisor in the fast-paced world of healthcare finance. His deep understanding of the pharmaceutical industry, coupled with his skills in biomanufacturing and drug delivery, positions him as a thought leader in the sector, dedicated to advancing the growth trajectories of the companies he serves. As he continues to spearhead key projects at Stifel, Tom remains committed to driving transformative outcomes in healthcare investment banking.
